Publikationen, an denen er mitarbeitet MARIONA JOVE FONT (24)

2024

  1. Human lifespan and sex-specific patterns of resilience to disease: a retrospective population-wide cohort study

    BMC Medicine, Vol. 22, Núm. 1

2023

  1. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134

  2. Lipidomic signature of stroke recurrence after transient ischemic attack

    Scientific Reports, Vol. 13, Núm. 1

  3. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort

    Atherosclerosis, Vol. 380

  4. Metabolipidomic Analysis in Patients with Obstructive Sleep Apnea Discloses a Circulating Metabotype of Non-Dipping Blood Pressure

    Antioxidants, Vol. 12, Núm. 12

  5. Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome

    Aging Cell, Vol. 22, Núm. 6

2022

  1. Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  2. Ischemia preconditioning induces an adaptive response that defines a circulating metabolomic signature in ischemic stroke patients

    Journal of Cerebral Blood Flow and Metabolism, Vol. 42, Núm. 12, pp. 2201-2215

  3. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

  4. Plasma profiling reveals a blood-based metabolic fingerprint of obstructive sleep apnea

    Biomedicine and Pharmacotherapy, Vol. 145

2021

  1. Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer's disease

    Sleep, Vol. 44, Núm. 2

2019

  1. A prospective pilot study using metabolomics discloses specific fatty acid, catecholamine and tryptophan metabolic pathways as possible predictors for a negative outcome after severe trauma

    Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, Vol. 27, Núm. 1

  2. Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project

    Cardiovascular Diabetology, Vol. 18, Núm. 1

  3. Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis

    Scientific reports, Vol. 9, Núm. 1, pp. 11313

  4. Lung function measurements in the prediabetes stage: data from the ILERVAS Project

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1005-1012

  5. Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project

    Diabetes and Metabolism

2018

  1. Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia

    Molecular Neurobiology, Vol. 55, Núm. 7, pp. 6193-6200

2017

  1. Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients

    Oncotarget, Vol. 8, Núm. 65, pp. 109018-109026

2016

  1. Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients

    EBioMedicine, Vol. 14, pp. 131-138

  2. Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

    Oncotarget, Vol. 7, Núm. 32, pp. 52364-52374